glp 1 and ulcerative colitis GLP-1 medications are a major focus for scientists right now. Here's what's happening: between 2024 and 2025, at least six studies have been published in respected journals like Oxford Engineered probiotic restores GLP-1 signaling

unmeasured or imperfectly measured variables not captured in the electronic health recordsuch as socioeconomic status or specific lifestyle interventions (eg, diet, exercise)could still bias the results if they were associated with both treatment initiation and the outcomes

10.3389/fphar.2019.01552 [DOI] [PMC free article] [PubMed] [Google Scholar] 38.Gong Q, Li Y, Ma H, Guo W, Kan X, Xu D, Liu J, Fu S

So even though there were steps that employees had to take, it was usually denied the first time and they had to go through an appeal process

doi: 10.1016/j.sxmr.2018.02.004

Glucagon-like Peptide-1 Receptor: Mechanisms and Advances in Therapy

2024 [cited 2025 December, 20]